Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial

[1]  K. Verbeke,et al.  Short chain fatty acids in human gut and metabolic health. , 2020, Beneficial microbes.

[2]  I. Martínez,et al.  Gut microbiota modulation with long-chain corn bran arabinoxylan in adults with overweight and obesity is linked to an individualized temporal increase in fecal propionate , 2020, Microbiome.

[3]  Suisha Liang,et al.  The Gut Microbiota Profile in Children with Prader–Willi Syndrome , 2020, Genes.

[4]  Wenjuan Xu,et al.  A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: the similar and complementary antidiabetic properties of Type 3 Resistant Starch from Canna edulis and Metformin. , 2020, Pharmacological research.

[5]  N. Napoli,et al.  227-OR: The Effect of Dietary Fiber in Combination with Metformin Therapy in Type 2 Diabetes , 2020, Diabetes.

[6]  E. Elinav,et al.  Interaction between microbiota and immunity in health and disease , 2020, Cell Research.

[7]  J. Walter,et al.  Precision Microbiome Modulation with Discrete Dietary Fiber Structures Directs Short-Chain Fatty Acid Production. , 2020, Cell host & microbe.

[8]  S. O'keefe.  The association between dietary fibre deficiency and high-income lifestyle-associated diseases: Burkitt's hypothesis revisited. , 2019, The lancet. Gastroenterology & hepatology.

[9]  R. Haeusler,et al.  Bile acids in glucose metabolism and insulin signalling — mechanisms and research needs , 2019, Nature Reviews Endocrinology.

[10]  J. Walter,et al.  The Effect of Isolated and Synthetic Dietary Fibers on Markers of Metabolic Diseases in Human Intervention Studies: A Systematic Review. , 2019, Advances in nutrition.

[11]  William A. Walters,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[12]  J. Raes,et al.  Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study , 2019, Nature Medicine.

[13]  P. Zeitler.  Progress in understanding youth-onset type 2 diabetes in the United States: recent lessons from clinical trials , 2019, World Journal of Pediatrics.

[14]  L. T. Te Morenga,et al.  Carbohydrate quality and human health: a series of systematic reviews and meta-analyses , 2019, The Lancet.

[15]  S. Rampelli,et al.  Pre-obese children’s dysbiotic gut microbiome and unhealthy diets may predict the development of obesity , 2018, Communications Biology.

[16]  S. Rampelli,et al.  Pre-obese children’s dysbiotic gut microbiome and unhealthy diets may predict the development of obesity , 2018, Communications Biology.

[17]  J. Parkhill,et al.  Impact of carbohydrate substrate complexity on the diversity of the human colonic microbiota , 2018, FEMS microbiology ecology.

[18]  D. Schillinger,et al.  Review of Metformin Use for Type 2 Diabetes Prevention. , 2018, American journal of preventive medicine.

[19]  H. Tun,et al.  Postnatal exposure to household disinfectants, infant gut microbiota and subsequent risk of overweight in children , 2018, Canadian Medical Association Journal.

[20]  G. Silecchia,et al.  Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns , 2018, Front. Microbiol..

[21]  K. Kristiansen,et al.  Prevotella-to-Bacteroides ratio predicts body weight and fat loss success on 24-week diets varying in macronutrient composition and dietary fiber: results from a post-hoc analysis , 2018, International Journal of Obesity.

[22]  E. Jensen,et al.  Type 2 Diabetes in Youth: New Lessons from the SEARCH Study , 2018, Current Diabetes Reports.

[23]  Y. Nie,et al.  Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives , 2018, Protein & Cell.

[24]  Zhenghong Xu,et al.  Prebiotic Mannan-Oligosaccharides Augment the Hypoglycemic Effects of Metformin in Correlation with Modulating Gut Microbiota. , 2018, Journal of agricultural and food chemistry.

[25]  H. Tun,et al.  Roles of Birth Mode and Infant Gut Microbiota in Intergenerational Transmission of Overweight and Obesity From Mother to Offspring , 2018, JAMA pediatrics.

[26]  Chenhong Zhang,et al.  Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes , 2018, Science.

[27]  E. Blaak,et al.  Gastrointestinal Transit Time, Glucose Homeostasis and Metabolic Health: Modulation by Dietary Fibers , 2018, Nutrients.

[28]  T. R. Licht,et al.  Aberrant intestinal microbiota in individuals with prediabetes , 2018, Diabetologia.

[29]  B. Finlay,et al.  Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting , 2017, The Journal of allergy and clinical immunology.

[30]  J. Coad,et al.  Interindividual variability in gut microbiota and host response to dietary interventions , 2017, Nutrition reviews.

[31]  Luis Pedro Coelho,et al.  Towards standards for human fecal sample processing in metagenomic studies , 2017, Nature Biotechnology.

[32]  J. Walter,et al.  Modulation of the Gastrointestinal Microbiome with Nondigestible Fermentable Carbohydrates To Improve Human Health. , 2017, Microbiology spectrum.

[33]  F. Guarner,et al.  Colonic gas homeostasis: Mechanisms of adaptation following HOST‐G904 galactooligosaccharide use in humans , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[34]  H. Flint,et al.  The impact of nutrition on intestinal bacterial communities. , 2017, Current opinion in microbiology.

[35]  R. Leis,et al.  Metformin for Obesity in Prepubertal and Pubertal Children: A Randomized Controlled Trial , 2017, Pediatrics.

[36]  David Torrents,et al.  Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug , 2017, Nature Medicine.

[37]  A. Verrotti,et al.  Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome , 2017, Nutrients.

[38]  Markus Schöttle,et al.  A Role for IT , 2017, ATZelektronik worldwide.

[39]  J. M. G. Gomes,et al.  Metabolic endotoxemia and diabetes mellitus: A systematic review. , 2017, Metabolism: clinical and experimental.

[40]  S. Wood,et al.  Effect on Insulin, Glucose and Lipids in Overweight/Obese Australian Adults of 12 Months Consumption of Two Different Fibre Supplements in a Randomised Trial , 2017, Nutrients.

[41]  A. Salvatoni,et al.  Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[42]  P. Bork,et al.  Human gut microbes impact host serum metabolome and insulin sensitivity , 2016, Nature.

[43]  T. Schmidt,et al.  Variable responses of human microbiomes to dietary supplementation with resistant starch , 2016, Microbiome.

[44]  G. Mullin,et al.  The Gut Microbiome and Obesity , 2016, Current Oncology Reports.

[45]  J. Argente,et al.  Insulin resistance in prepubertal obese children correlates with sex-dependent early onset metabolomic alterations , 2016, International Journal of Obesity.

[46]  G. Bray,et al.  Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. , 2016, The Journal of clinical endocrinology and metabolism.

[47]  S. Hadjiyannakis,et al.  LMS tables for waist-circumference and waist-height ratio Z-scores in children aged 5–19 y in NHANES III: association with cardio-metabolic risks , 2015, Pediatric Research.

[48]  P. Bork,et al.  Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children , 2015, EBioMedicine.

[49]  F. Levenez,et al.  Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology , 2015, Gut.

[50]  A. Kozyrskyj,et al.  The Infant Gut Microbiome: Evidence for Obesity Risk and Dietary Intervention , 2015, Nutrients.

[51]  F. Greenway,et al.  Addition of a Gastrointestinal Microbiome Modulator to Metformin Improves Metformin Tolerance and Fasting Glucose Levels , 2015, Journal of diabetes science and technology.

[52]  K. Main,et al.  Validity of Self-Assessment of Pubertal Maturation , 2015, Pediatrics.

[53]  B. Viollet,et al.  Metformin: from mechanisms of action to therapies. , 2014, Cell metabolism.

[54]  R. Hamman,et al.  The SEARCH for Diabetes in Youth Study: Rationale, Findings, and Future Directions , 2014, Diabetes Care.

[55]  G. Frost,et al.  The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents , 2014, International Journal of Obesity.

[56]  H. Nittono,et al.  A simple and accurate HPLC method for fecal bile acid profile in healthy and cirrhotic subjects: validation by GC-MS and LC-MS[S] , 2014, Journal of Lipid Research.

[57]  G. Grover,et al.  Combining sitagliptin/metformin with a functional fiber delays diabetes progression in Zucker rats. , 2014, The Journal of endocrinology.

[58]  F. Bäckhed,et al.  Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits , 2014, Cell.

[59]  Cheryl R. Clark,et al.  Dietary fiber intake and cardiometabolic risks among US adults, NHANES 1999-2010. , 2013, The American journal of medicine.

[60]  J. Clemente,et al.  Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice , 2013, Science.

[61]  Lucie Geurts,et al.  Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity , 2013, Proceedings of the National Academy of Sciences.

[62]  D. Czyzewski,et al.  Reliability and validity of a modified Bristol Stool Form Scale for children. , 2011, The Journal of pediatrics.

[63]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[64]  P. Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[65]  H. Flint,et al.  High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. , 2011, The American journal of clinical nutrition.

[66]  V. Tremaroli,et al.  A role for the gut microbiota in energy harvesting? , 2010, Gut.

[67]  J. Kuk,et al.  Metabolic risk varies according to waist circumference measurement site in overweight boys and girls. , 2010, The Journal of pediatrics.

[68]  D. Hill,et al.  Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance , 2009, Endocrine.

[69]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[70]  J. Slavin,et al.  Gastrointestinal Effects of Low-Digestible Carbohydrates , 2009, Critical reviews in food science and nutrition.

[71]  M. Benninga,et al.  A Dietary Fiber Mixture versus Lactulose in the Treatment of Childhood Constipation: A Double-blind Randomized Controlled Trial , 2008, Journal of pediatric gastroenterology and nutrition.

[72]  W. Tamborlane,et al.  Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes , 2007, Pediatric diabetes.

[73]  S. Kurtoğlu,et al.  Homeostasis Model Assessment Is More Reliable Than the Fasting Glucose/Insulin Ratio and Quantitative Insulin Sensitivity Check Index for Assessing Insulin Resistance Among Obese Children and Adolescents , 2005, Pediatrics.

[74]  A. Cardello,et al.  Development and testing of a labeled magnitude scale of perceived satiety , 2005, Appetite.

[75]  M. Uusitupa,et al.  Comparative evaluation of simple indices of insulin resistance. , 2004, Metabolism: clinical and experimental.

[76]  Michael Seid,et al.  PedsQL™ 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in Healthy and Patient Populations , 2001, Medical care.

[77]  M. Freemark,et al.  The Effects of Metformin on Body Mass Index and Glucose Tolerance in Obese Adolescents With Fasting Hyperinsulinemia and a Family History of Type 2 Diabetes , 2001, Pediatrics.

[78]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[79]  P. Crocker,et al.  Convergent Validity of the Physical Activity Questionnaire for Adolescents , 1997 .

[80]  P. Crocker,et al.  Validation of the Physical Activity Questionnaire for Older Children , 1997 .

[81]  P Dempster,et al.  A new air displacement method for the determination of human body composition. , 1995, Medicine and science in sports and exercise.

[82]  C. Osmond,et al.  Understanding Oral Glucose Tolerance: Comparison of Glucose or Insulin Measurements During the Oral Glucose Tolerance Test with Specific Measurements of Insulin Resistance and Insulin Secretion , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[83]  J. Lampe,et al.  The gut microbiome and obesity. , 2012, Nestle Nutrition Institute workshop series.

[84]  S. Heymsfield,et al.  Body composition analysis: Cellular level modeling of body component ratios. , 2008, International journal of body composition research.

[85]  R. Muniyappa,et al.  Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. , 2008, American journal of physiology. Endocrinology and metabolism.

[86]  J. Janosky,et al.  Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. , 2004, The Journal of pediatrics.

[87]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[88]  E. Bonora,et al.  Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. , 2000, Diabetes care.